Cabotegravir

(3S,11aR) -N-[ (2,4-Difluorophenyl) methyl]-2,3,5,7,11,11a-hexahydro-6-hydroxy-3-methyl-5,7-dioxooxazolo[3,2-a]pyrido[1,2- d]pyrazine-8-carboxamide; (3s,11Ar) -n- (2,4-difluorobenzyl) -6-hydroxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-a]pyrido[1,2- d]pyrazine-8-carboxamide; Apretude; GSK 1265744A; GSK 744; (3S,11aR) -N- (2,4-difluorobenzyl) -6-hydroxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide

(3S,11aR) -N-[ (2,4-Difluorophenyl) methyl]-2,3,5,7,11,11a-hexahydro-6-hydroxy-3-methyl-5,7-dioxooxazolo[3,2-a]pyrido[1,2- d]pyrazine-8-carboxamide; (3s,11Ar) -n- (2,4-difluorobenzyl) -6-hydroxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-a]pyrido[1,2- d]pyrazine-8-carboxamide; Apretude; GSK 1265744A; GSK 744; (3S,11aR) -N- (2,4-difluorobenzyl) -6-hydroxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide